AXGN
|
AxoGen, Inc.
|
0.14%
|
US
|
NASDAQ
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.14%
|
US
|
NASDAQ
|
ANIK
|
Anika Therapeutics Inc.
|
0.14%
|
US
|
NASDAQ
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.14%
|
US
|
NASDAQ
|
ALBO
|
Albireo Pharma, Inc.
|
0.14%
|
US
|
NASDAQ
|
KZR
|
Kezar Life Sciences, Inc.
|
0.14%
|
US
|
NASDAQ
|
SIBN
|
SI-BONE, Inc.
|
0.13%
|
US
|
NASDAQ
|
NKTR
|
Nektar Therapeutics
|
0.13%
|
US
|
NASDAQ
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
LQDA
|
Liquidia Technologies, Inc.
|
0.13%
|
US
|
NASDAQ
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.13%
|
US
|
NASDAQ
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
CRBU
|
Caribou Biosciences, Inc.
|
0.13%
|
US
|
NASDAQ
|
BNGO
|
Bionano Genomics, Inc.
|
0.13%
|
US
|
NASDAQ
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.13%
|
US
|
NASDAQ
|
OSUR
|
OraSure Technologies, Inc.
|
0.12%
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
0.12%
|
US
|
NASDAQ
|
NNOX
|
Nano-X Imaging Ltd.
|
0.12%
|
US
|
NASDAQ
|
MGNX
|
MacroGenics, Inc.
|
0.12%
|
US
|
NASDAQ
|
MDXG
|
MiMedx Group, Inc
|
0.12%
|
US
|
NASDAQ
|